The API ZYM system was contpared with four anaerobe identification systems for the definitive identification of Clostridium difficile by using 88 cultures of C. difficile grown on Mueller-Hinton blood agar medium. The API ZYM system yielded a distinct and consistent enzyme profile for all test strains, whereas the sensitivities of the other systems in identifying C. difficile ranged from 78 to 96% (AN-Ident, 17.9%; RapID-ANA, 88.6%; Minitek Anaerobe II, 90.9%; and API 20A, 95.5%). The API ZYM system is highly reliable in identifying C. difficile accurately, is rapid, and is relatively simple to use.
Clostridium difficile is a well-recognized human pathogen, and most clinical laboratories now routinely process specimens for this agent. Isolation by culturing is a common approach, and although C. difficile can be presumptively identified in many instances by its culture characteristics and cellular morphology, definitive identification requires additional tests. Several anaerobe identification systems are now commercially available in convenient kit forms. The ability of these kits to identify anaerobes in general has been evaluated by several workers, but their usefulness specifically for the identification of C. difficile has not been fully assessed (3, 5, 8, 12) . The API ZYM system (Analytab Products, Plainview, N.Y.) has recently been reported to be a rapid and reliable method for the identification of C. difficile (10, 11) . This system, however, has not been evaluated in comparison with other systems available for identifying anaerobes. Also, at present, there is no database for the ready identification of anaerobes by this system. We carried out a study to further define the usefulness of the API ZYM system in identifying C. difficile specifically in comparison with four other commercial anaerobe identification systems.
The API ZYM system is a semiquantitative micromethod consisting of 20 microcupules, 19 of which contain dehydrated chromogenic substrates for detecting 19 preformedenzyme activities. The test strips are inoculated and incubated aerobically at 37°C for 4 h, and then two reagents are added to develop the chromogenic substrates. The resultant colorimetric reactions are indicative of the degree of enzyme activity and are graded on a scale of 0 to 5 in comparison with the control well and a color chart. The other kits evaluated in the study included RapID-ANA (Innovative Diagnostic Systems, Decatur, Ga.), AN (2) . AlI cultures were maintained on Mueller-Hinton II agar base (BBL 11438; BBL Microbiology Systems) containiing 5% sheep blood.
Test strains were. grown on Muellér-Hinton blood agar medium anaerobically at 37°C for 48 h. The growth was emulsified in an appropriate inoculum fluid to yield a suspension of uniform turbidity, as recommended by each manufacturer. The panels were inoculated and incubated, and the results were read and interpreted in accordance with the instructions of the manufacturers; however, when supplementary tests were indicated, these were not carried out. As indicated in a recent report (6) , the recommended 24-h incubation of API 20A was extended to 48 h. To determine the reproducibility of the test reactions in individual panels, we picked seven isolates of C. difficile at random and tested them three times with each of the five systems in accordance with the above-described protocol. To determine the effect of culture media on the outcome of the API ZYM reactions, we compared the growth of 18 isolates of C. difficile from Mueller-Hinton blood agar with the growth of isolates from Columbia agar (code CM331; Oxoid Canada Ltd., Nepean, Ontario, Canada), brucella agar (catalog no. M08400; GIBCO Canada, Burlington, Ontario, Cahada), and brain heart infusion agar (Difco Laboratories, Detroit, Mich.), all of which contained 5% sheep blood.
In the comparative evaluations of the identification systems, the AN-Ident system correctly identified 60 (77.9%) of the 77 C. difficile strains tested to the species level and 15 to the genus level, with two incorrect identifications; the RapID-ANA system correctly identified 78 (88.6%) of the 88 
a Discrepant enzyme profiles of some species were not included or were modified when combined with data obtained for a larger number of strains in separate studies.
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Clostridium spp. in previous evaluations of the API ZYM system (10, 11) . A recent study compared the API AN-Ident, Minitek, and RapID-ANA systems for the identification of C. difficile and found a sensitivity of 9% for the API AN-Ident system (4) . Among the five systems we evaluated, the API AN-Ident system was found to have the lowest sensitivity (78%), but this was far higher than the sensitivity of 9% previously reported. Similarly, we found a higher sensitivity for Minitek (91%) than the 66% previously reported (4) . However, in contrast to the 100% sensitivity previously reported for the RapID-ANA system (4), we found the sensitivity to be only 89%. These discrepancies are difficult to explain. Whether the differences reflect improvements or changes in the identification systems concerned is hot known. Nevertheless, our observation of a 95.5% sensitivity for the API 20A system in identifying C. difficile was almost identical to that in a recent report (6) .
The API ZYM system previously has been reported to be a rapid and reliable method for the identification of a wide variety of microorganisms (7, 9, (13) (14) (15) (16) . Our results indicate that the API ZYM system is an excellent method for the identification of C. difficile as well and confirm and further extend the earlier observations on the application of this system in specifically identifying C. difficile (1, 10, 11) . We did not test the specificity of this system in identifying C. difficile; nevertheless, it is evident from previous studies that the API ZYM profile of C. difficile is sufficiently characteristic to allow for a definitive differentiation of this organism from other menibers of the genus Clostridium ( Table 2 ). The compositions of culture media influence API ZYM enzyme activities, and Columbia and brain heart infusion media have been found previously to yield uniform results (10) . We compared Columbia, brain heart infusion, and brucella media with Mueller-Hinton medium and found no significant differences; it should be pointed out that we tested only 48-h cultures. In previous evaluations of the API ZYM system for identifying C. difficile, Columbia blood agar and Centers for Disease Control anaerobe blood agar cultures were used (10, 11) . Whether differences in the culture medium used could be reasons for the discrepancies observed between individual evaluations of the API ZYM system, including our own, is not known (1, 10, 11) ( Table 2) . Variations between batches of API ZYM strips, however, have been observed (11) , and these could account for the discrepancies.
In conclusion, we consider the API ZYM system to be highly reliable in identifying C. difficile. It is also rapid and relatively simple to use, and the test reactions are highly reproducible and easy to interpret.
